The significant variance in MDA levels across different severity stages in our study highlights the sensitivity of MDA as a biomarker, potentially surpassing traditional inflammatory markers such as CRP in detecting subtle changes in oxidative stress related to CAD. Here, CRP is linked to coronary artery disorder.